Donald A. Denkhaus - 05 Jan 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ Donald A. Denkhaus
Issuer symbol
CPRX
Transactions as of
05 Jan 2022
Net transactions value
+$167,500
Form type
4
Filing time
06 Jan 2022, 15:50:21 UTC
Previous filing
30 Dec 2021
Next filing
11 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $167,500 +50,000 +22% $3.35 277,666 05 Jan 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -50,000 -13% $0.000000 324,834 05 Jan 2022 Common Stock 50,000 $3.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Derivative securities vested in three equal tranches beginning on February 19, 2016.